Tag: pharma

DEEP DIVE: Opioids ~ Unsupervised Methods for Kick-back Detection

by Nikolay Rodionov

Alternative Title: How to kill 6 days during Spring Break. The unmasking of the opioids epidemic over the last several years has brought new scrutiny to marketing practices associated with high-risk pharmaceuticals products; Exposé journalistic efforts have been especially effective in shedding light on how misinformation and miscalculations of associated risk factors catalysed a torrent … Continue reading DEEP DIVE: Opioids ~ Unsupervised Methods for Kick-back Detection

OpenPayments Data #3: Subsidiary Filings Prt. 2

by Nikolay Rodionov

First, some context: The requirement for direct-to-doctor (D2D) marketing transparency was enacted by Physician Payment Sunshine Act as part of ACA reforms in 2010. The call for transparency was initiated in response to concerns that D2D marketing practices by pharmaceutical & medical device companies may exert on undue influence on physician prescription practices. These concerns … Continue reading OpenPayments Data #3: Subsidiary Filings Prt. 2

rbindlist() for all of you list-of-dataframe monsters

by Nikolay Rodionov

ALAS! Why is gov’t data so terribly structured?! I’ve been working with the CMS Open Payments data recently because the annual datasets offer enough granular info to allow for good modeling practices and pharmaceutical marketing practices are pretty interesting from a policy stand-point. My only harp with the data is it’s poor data structure and … Continue reading rbindlist() for all of you list-of-dataframe monsters